Eton Pharmaceuticals Submits New Drug Application for Topiramate Oral Solution
uncategorized
Eton Pharmaceuticals has submitted a new drug application (NDA) for topiramate oral solution — an anticonvulsant formerly known as ET-101 — to the U.S. Food and Drug Administration (FDA). The NDA covers three ... Read more